StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)

Close on Nov 17, 2026Market cap $37.82MP/E –Yield –

Earnings

Elutia's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 10, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$1.10M
-66.7% on a year earlier
EPS, Q3 FY2026
–
-$0.19 a year earlier
Latest guidance
Issued
Jan 9, 2023 · 2 items

Quarterly results

Revenue and earnings per share from each of Elutia's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 10, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$1.10M-66.7%–Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026during market hours$2.40M-61.9%–Release
Q1 FY2026ended Mar 31, 2026May 14, 2026during market hours$3.10M-48.3%–Release
Q4 FY2025ended Dec 31, 2025Mar 11, 2026during market hours$3.30M––Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025during market hours$3.30M-44.1%-$0.19Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours$6.30M0.0%-$0.26Release
Q1 FY2025ended Mar 31, 2025May 8, 2025during market hours$6.00M-10.4%-$0.21Release
Q4 FY2024ended Dec 31, 2024Feb 3, 2025before the open–––Filing
Q3 FY2024ended Sep 30, 2024Nov 14, 2024during market hours$5.90M-3.3%–Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024during market hours$6.30M-38.8%-$1.14Release
Q1 FY2024ended Mar 31, 2024May 9, 2024during market hours$6.70M-48.9%-$0.75Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Elutia guided for has been reported

Guidance vs results

The last range Elutia gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q4 FY2022Revenue$12.50M – $12.70M$12.70MWithin range

Guidance history

Every forecast Elutia put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Jan 9, 2023net salesQ4 FY2022$12.50M – $12.70MNew
Jan 9, 2023net salesFY2022$49.00M – $49.20MNarrowed
Aug 11, 2022expected growthFY2022+11% – +18%Reaffirmed
Aug 11, 2022total net salesFY2022$47.00M – $50.00MReaffirmed
May 9, 2022total net salesFY2022$47.00M – $50.00MReaffirmed
Mar 3, 2022Gross margin, excluding intangible asset amortizationFY202250%New
Mar 3, 2022expected growthFY2022+11% – +18%New
Mar 3, 2022total net salesFY2022$47.00M – $50.00MNew
Nov 9, 2021net salesFY2021$47.00M – $48.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Elutia filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Results
  5. Update
  6. Results
  7. Results
  8. News
  9. Results
  10. Results
  11. Update
  12. Update
  13. Update
  14. Update
  15. Results

See a number that looks wrong?